Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet

NCT02589457 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: CKD-390
DRUG: Viread® tablet

Sponsor

Chong Kun Dang Pharmaceutical